Literature DB >> 9638361

Regulation of interferon-gamma production by IL-12 and IL-18.

H Okamura1, S Kashiwamura, H Tsutsui, T Yoshimoto, K Nakanishi.   

Abstract

IL-18 (interferon-inducing factor) and IL-12 exhibit a marked synergism in interferon-gamma induction in T cells. Investigations into the mechanism of this synergism have revealed that IL-12 upregulates expression of the IL-18 receptor on cells producing interferon-gamma. Although IL-18 does not induce the development of Th1 cells, it is essential for the effective induction and activation of Th1 cells by IL-12. As for natural killer cells, IL-18 seems to activate them independently of IL-12. Although IL-12 and IL-18 activate both innate and acquired immunity, their excessive production by activated macrophages may induce multiple organ disorders including disruption of the immune system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638361     DOI: 10.1016/s0952-7915(98)80163-5

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  113 in total

1.  Effect of exogenous interleukin-18 (IL-18) and IL-12 in the course of Brucella abortus 2308 infection in mice.

Authors:  Paolo Pasquali; Rosanna Adone; Louis C Gasbarre; Claudia Pistoia; Franco Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

Authors:  N R Chu; H B Wu; T Wu; L J Boux; M I Siegel; L A Mizzen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease.

Authors:  Othmar Ludwiczek; Arthur Kaser; Daniela Novick; Charles A Dinarello; Menachem Rubinstein; Wolfgang Vogel; Herbert Tilg
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

4.  Seeligeriolysin O, a cholesterol-dependent cytolysin of Listeria seeligeri, induces gamma interferon from spleen cells of mice.

Authors:  Yutaka Ito; Ikuo Kawamura; Chikara Kohda; Hisashi Baba; Takamasa Nomura; Terumi Kimoto; Isao Watanabe; Masao Mitsuyama
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  IκBζ is essential for natural killer cell activation in response to IL-12 and IL-18.

Authors:  Tohru Miyake; Takashi Satoh; Hiroki Kato; Kazufumi Matsushita; Yutaro Kumagai; Alexis Vandenbon; Tohru Tani; Tatsushi Muta; Shizuo Akira; Osamu Takeuchi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

6.  Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients.

Authors:  A Kaser; D Novick; M Rubinstein; B Siegmund; B Enrich; R O Koch; W Vogel; S H Kim; C A Dinarello; H Tilg
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

7.  Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Authors:  Jason D Price; Kim R Simpfendorfer; Radhakrishnam R Mantena; James Holden; William R Heath; Nico van Rooijen; Richard A Strugnell; Odilia L C Wijburg
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

8.  Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis.

Authors:  Markus Entleutner; Tobias Traeger; Alexandra Westerholt; Bernhard Holzmann; Albrecht Stier; Klaus Pfeffer; Stefan Maier; Claus-Dieter Heidecke
Journal:  Int J Colorectal Dis       Date:  2005-03-09       Impact factor: 2.571

Review 9.  Role of cytokines in inflammatory bowel disease.

Authors:  Fausto Sanchez-Munoz; Aaron Dominguez-Lopez; Jesus-K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

10.  IL18 polymorphism is associated with an increased risk of Crohn's disease.

Authors:  Kazuo Tamura; Yoshihiro Fukuda; Hiroko Sashio; Naohisa Takeda; Hiroko Bamba; Tadashi Kosaka; Shin Fukui; Koji Sawada; Kazutami Tamura; Masamichi Satomi; Takahiro Yamada; Takehira Yamamura; Yoshihiro Yamamoto; Jun-ichi Furuyama; Haruki Okamura; Takashi Shimoyama
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.